MARKET

ASRT

ASRT

Assertio Holdings Inc
NASDAQ
0.7675
-0.0166
-2.12%
After Hours: 0.7520 -0.0155 -2.02% 19:02 12/05 EST
OPEN
0.7720
PREV CLOSE
0.7841
HIGH
0.7887
LOW
0.7590
VOLUME
272.04K
TURNOVER
--
52 WEEK HIGH
1.079
52 WEEK LOW
0.5137
MARKET CAP
73.87M
P/E (TTM)
-2.4435
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ASRT last week (1124-1128)?
Weekly Report · 6d ago
Weekly Report: what happened at ASRT last week (1117-1121)?
Weekly Report · 11/24 10:29
Assertio Therapeutics Announces Leadership Change with CEO Resignation
TipRanks · 11/21 22:32
Assertio Holdings CEO Brendan O'Grady Resigns
Reuters · 11/21 22:01
Weekly Report: what happened at ASRT last week (1110-1114)?
Weekly Report · 11/17 10:30
Director David Matthew Stark Reports Disposal of Assertio Holdings Inc. Common Shares
Reuters · 11/12 23:00
Immix Biopharma Appoints Michael Grabow as Chief Commercial Officer
Reuters · 11/12 13:45
Assertio Therapeutics: Strategic Moves and Leadership Changes Drive Buy Rating
TipRanks · 11/12 13:05
More
About ASRT
Assertio Holdings, Inc. is a pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through the acquisition or licensing of approved products. Its commercial capabilities include marketing through both a sales force and an omni-channel promotion model, market access through payor contracting, and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, and CAMBIA (diclofenac potassium for oral solution). INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID). Otrexup is a once weekly single-dose auto-injector containing methotrexate.

Webull offers Assertio Holdings Inc stock information, including NASDAQ: ASRT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASRT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASRT stock methods without spending real money on the virtual paper trading platform.